title: Minimal guidelines for the monitoring of early clinical trials (phase I-II) in Europe under CRC/EORTC/NCI joint agreement.
authors.forename: C
authors.initials: C
authors.lastname: Arrigo
authors.forename: I J
authors.initials: IJ
authors.lastname: Koier
authors.forename: J G
authors.initials: JG
authors.lastname: McVie
authors.forename: S
authors.initials: S
authors.lastname: Marsoni
authors.forename: E
authors.initials: E
authors.lastname: Newlands
authors.forename: G
authors.initials: G
authors.lastname: Schwartsmann
mesh_terms: D002985:Clinical Protocols; D002986:Clinical Trials as Topic / Q000592:standards*; D004341:Drug Evaluation; D005060:Europe; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*